Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis

Journal of Investigative Dermatology

Volumn 125, Issue 4, 2005, Pages 738-745

  Howell, Michael D ^a,b   Novak, Natalija ^c   Bieber, Thomas ^c   Pastore, Saveria ^d   Girolomoni, Giampiero ^d   Boguniewicz, Mark ^a,b   Streib, Joanne ^a,b   Wong, Cathy ^e,f   Gallo, Richard L ^e,f   Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF BONN   (Germany)

^d LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Anti microbial peptides; Cytokines; Extrinsic atopic dermatitis; Intrinsic atopic dermatitis

Indexed keywords

BETA DEFENSIN 2; GAMMA INTERFERON; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; DEFB4 PROTEIN, HUMAN; INTERLEUKIN 13;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; EXPLANT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SKIN DEFECT; BIOSYNTHESIS; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CELLS, CULTURED; DERMATITIS, ATOPIC; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKIN-13; MIDDLE AGED; PSORIASIS;

EID: 27744478760     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23776.x     Document Type: Article

References (33)

1. Akdis CA, Akdis M, Simon D, et al: T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 113:628-634, 1999
2. Asadullah K, Sterry W, Stephanek K, et al: IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: A new therapeutic approach. J Clin Invest 101:783-794, 1998
3. Borish L: IL-10: Evolving concepts. J Allergy Clin Immunol 101:293-297, 1998
4. Chernoff AE, Granowitz EV, Shapiro L, et al: A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 154:5492-5499, 1995
5. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M Trinchieri G: Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041-1048, 1993
6. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG de Vries JE: Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991
7. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151:1224-1234, 1993
8. Dorschner RA, Pestonjamasp VK, Tamakuwala S, et al: Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117:91-97, 2001
9. Erdag G, Morgan JR: Interleukin-1 alpha and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann Surg 235:113-124, 2002
10. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822, 1991
11. Gallo RL, Murakami M, Ohtake T Zaiou M: Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 110:823-831, 2002
12. Grossman RM, Krueger J, Yourish D, et al: Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367-6371, 1989
13. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venerol (Stockh) 92:44-47, 1980
14. Harder J, Bartels J, Christophers E, Schroder JM: A peptide antibiotic from human skin. Nature 387:861, 1997
15. Hauk PJ, Hamid QA, Chrousos GP, Leung DY: Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 105:782-787, 2000
16. Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DY: Selective killing of vaccinia virus by LL-37: Implications for eczema vaccinatum. J Immunol 172:1763-1767, 2004
17. Jeong CW, Ahn KS, Rho NK, et al: Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR. Clin Exp Allergy 33:1717-1724, 2003
18. Johansson SG, Bieber T, Dahl R, et al: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113:832-836, 2004
19. Kagi MK, Wuthrich B, Montano E, Barandun J, Blaser K, Walker C: Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Int Arch Allergy Immunol 103:332-340, 1994
20. Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, Geha RS: IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 112:1058-1066, 2003
21. Lester MR, Hofer MF, Gately M, Trumble A, Leung DY: Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol 154:6174-6181, 1995
22. Leung DY, Bieber T: Atopic dermatitis. Lancet 361:151-160, 2003
23. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA: New insights into atopic dermatitis. J Clin Invest 113:651-657, 2004
24. Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, Liu L, Ganz T: Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118:275-281, 2002
25. Nizet V, Ohtake T, Lauth X, et al: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454-457, 2001
26. Nomura I, Goleva E, Howell MD, et al: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262-3269, 2003
27. Novak N, Bieber T: Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 112:252-262, 2003
28. Ohmen JD, Hanifin JM, Nickoloff BJ, et al: Overexpression of IL-10 in atopic dermatitis Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 154:1956-1963, 1995
29. Ong PY, Ohtake T, Brandt C, et al: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-1160, 2002
30. Oppel T, Schuller E, Gunther S, Moderer M, Haberstok J, Bieber T, Wollenberg A: Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitis. Br J Dermatol 143:1193-1198, 2000
31. Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A, Girolomoni G: Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 99:3009-3017, 1997
32. Seifert M, Gruenberg BH, Sabat R, et al: Keratinocyte unresponsiveness towards interleukin-10: Lack of specific binding due to deficient IL-10 receptor 1 expression. Exp Dermatol 12:137-144, 2003
33. van der Sluijs KF, van Elden LJ, Nijhuis M, et al: IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 172:7603-7609, 2004